Lixiong Dai

机构：Wenzhou University, Wenzhou Medical University, Second Affiliated Hospital & Yuying Children's Hospital of Wenzhou Medical University, University of Chinese Academy of Sciences · ORCID：0000-0003-0983-2463

发表论文 62 篇 · 总被引 1025 次 · h-index 16

代表论文

• Rational Design of Mono-Substituted Gd-DOTA as Highly Stable and Efficient MRI Contrast Agents for Hepatobiliary and Inflammation Imaging (2024 · Journal of Medicinal Chemistry · 被引 16)
• Chiral Strategy for Developing High-Performance Polymeric Gadolinium-Based MRI Contrast Agents for Vascular and Tumor Imaging (2025 · Chemical & Biomedical Imaging · 被引 13)
• Mn( ii )-MOF nanoparticles conjugated with EOB-PEG as high-performance hepatobiliary-specific MRI contrast agents (2025 · Nanoscale · 被引 10)
• Design of Mn(1,4-DO2A) derivatives as stable and inert contrast agents for magnetic resonance imaging (2025 · Communications Chemistry · 被引 7)
• Highly InertGd-DOTA-Based Contrast Agents with aLipophilic Side Chain for Hepatobiliary and Vascular Magnetic ResonanceImaging (2025 · Journal of Medicinal Chemistry · 被引 6)
• New Chiral Pyclen-Based Gadolinium(III) Complexes: Advancing Stability, Relaxivity, and Water Exchange for Improved Magnetic Resonance Imaging Probes (2025 · Journal of Medicinal Chemistry · 被引 6)